Imsight Medical Technology Company Limited has been voted as one of the top 50 A.I. companies in China (2017 & 2018) and Best Software Start-up in ICT awards (2018). lt is incubated by the Medical Image Analysis laboratory at The Chinese University of Hong Kong (CUHK). The company was founded by a group of professors and PhDs from CUHK together with former vice president of Fortune 500 companies. Imsight focuses on developing large-scale A.I. platforms for automated processing of medical images. Our first product cal1ed LungSight is an automatic early lung cancer detection software based on state-of-the-art A.I. technology. The product has been integrated with multiple 3A Hospitals in Mainland China and Hong Kong. The company is expanding rapidly with offices in Hong Kong, Shenzhen, Chengdu and Beijing of China while established collaborations with more than 50 hospitals and two A.l. research labs. 視見醫療科技有限公司2017及2018年被評為中國人工智能公司top50，並在2018年獲得資訊科技初創企業(軟件及應用服務)金獎。該公司由香港中文大學的一批教授和博士與財富500強公司副總裁共同創辦。視見醫療專注於開發醫學影像分析軟件和大型醫療影像自動化處理平台。肺部小結節放射影像人工智能分析系統為視見醫療首個研發的產品，該系統是基於神經網路技術自動檢測肺結節病變，有助於及早診斷及治療肺癌。公司發展迅速，於中國許多頂級三甲醫院建立穩定的合作關係，並在深圳，香港，成都和北京設立辦事處及研發中心。

Incu-Tech

2017

Biotech

TSSSU Company